SequelSEC

OneMedNet Corp ONMDW

Services-Commercial Physical & Biological Research · CIK 0001849380 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$292.00K
Fiscal year ended 2026-06-30
Operating income
-$2.26M
Fiscal year ended 2026-06-30
Free cash flow
-$1.88M
Fiscal year ended 2026-06-30

OneMedNet Corp (ONMDW) reported revenue of $292.00K and net income of -$2.17M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from OneMedNet Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.

Income

OneMedNet Corp income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$292.00K$96.00K$891.00K$177.00K$155.00K$137.00K$26.00K$142.00K$227.00K$248.00K
Cost of revenue$857.00K$476.00K$726.00K$399.00K$396.00K$361.00K$52.00K$226.00K$329.00K$317.00K
Gross profit-$565.00K-$380.00K$165.00K-$222.00K-$241.00K-$224.00K-$26.00K-$84.00K-$102.00K-$69.00K
Operating income-$2.26M-$2.55M-$3.08M-$2.24M-$2.06M-$2.22M-$2.72M-$2.34M-$2.45M-$2.10M
Net income-$2.17M-$2.45M-$3.14M-$741.00K$2.98M-$1.90M-$2.37M-$2.06M-$3.59M-$2.11M
Research & development$324.00K$311.00K$443.00K$323.00K$382.00K$348.00K$340.00K$298.00K$383.00K$445.00K
Weighted-average diluted sharesshares 58.02Mshares 55.32MUnavailableshares 52.62Mshares 38.41Mshares 34.10MUnavailableshares 29.27Mshares 25.18Mshares 24.92M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.04$-0.04Unavailable$-0.01$0.07$-0.06Unavailable$-0.07$-0.14$-0.08
Selling, general & administrative$1.37M$1.86M$2.80M$1.69M$1.44M$1.65M$2.35M$1.95M$1.97M$1.59M
General & administrative$981.00K$1.48M$2.38M$1.39M$1.18M$1.36M$2.14M$1.81M$1.72M$1.36M
Selling & marketing$391.00K$378.00K$426.00K$304.00K$257.00K$290.00K$207.00K$140.00K$253.00K$229.00K

Balance

OneMedNet Corp balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$358.00K$233.00K$585.00K$149.00K$122.00K$144.00K$172.00K$1.93M$407.00K$174.00K
Total assets$1.36M$1.51M$2.15M$1.51M$2.34M$1.73M$3.73M$4.39M$1.04M$750.00K
Current assets$1.31M$1.46M$2.10M$1.45M$2.27M$1.63M$3.62M$4.30M$956.00K$656.00K
Total liabilities$4.88M$5.59M$5.12M$5.44M$6.18M$18.28M$19.68M$18.66M$20.23M$16.45M
Current liabilities$4.73M$5.36M$4.82M$5.00M$6.16M$18.15M$19.23M$18.63M$20.05M$14.66M
Total equity incl. NCI-$3.52M-$4.08M-$2.96M-$3.94M-$3.84M-$16.55M-$15.95M-$14.27M-$19.19M-$15.70M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable$2.60MUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivable$664.00K$697.00K$495.00K$582.00K$254.00K$247.00K$213.00K$63.00K$75.00K$253.00K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt$132.00K$176.00K$220.00KUnavailableUnavailable$2.33M$2.32M$2.31M$2.39MUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

OneMedNet Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$1.88M-$1.54M-$1.71M-$1.75M-$2.19M-$1.85M-$2.00M-$1.90M-$1.51M-$1.55M
Capital expenditures$9.00K$2.00K$5.00K$0$3.00K$5.00K$35.00K$9.00K$1.00K$6.00K
Investing cash flow$56.00K$352.00K-$51.00K$1.11M-$670.00K$1.92M$365.00K-$2.34M-$1.00K-$6.00K
Financing cash flow$1.94M$838.00K$2.20M$666.00K$2.84M-$94.00K-$131.00K$5.47M$2.04M$1.68M
Net change in cash$125.00K-$352.00K$436.00K$27.00K-$22.00K-$28.00K-$1.76M$1.23M$533.00K$127.00K
Stock-based compensation$463.00K$431.00K$1.48M$142.00K$197.00K$208.00K$181.00K$207.00K$103.00K$137.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailable$11.00K$9.00K$10.00K$34.00K$12.00K$26.00K$10.00K$10.00K$11.00K

Derived

OneMedNet Corp derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow-$1.88M-$1.54M-$1.72M-$1.75M-$2.19M-$1.86M-$2.03M-$1.91M-$1.51M-$1.55M
Gross margin-193.5%-395.8%18.5%-125.4%-155.5%-163.5%-100.0%-59.2%-44.9%-27.8%
Operating margin-774.3%-2658.3%-345.9%-1262.7%-1331.0%-1623.4%-10446.2%-1645.1%-1081.1%-847.2%
FCF margin-645.2%-1608.3%-192.8%-987.0%-1414.2%-1356.9%-7811.5%-1346.5%-663.9%-626.2%
SBC / revenue158.6%449.0%166.7%80.2%127.1%151.8%696.2%145.8%45.4%55.2%
Current ratio0.28x0.27x0.43x0.29x0.37x0.09x0.19x0.23x0.05x0.04x
Revenue YoY growth88.4%-29.9%3326.9%24.6%-31.7%-44.8%-92.4%-56.4%31.2%24.0%
Net margin-743.8%Unavailable-352.4%-418.6%1923.9%Unavailable-9126.9%-1449.3%UnavailableUnavailable
R&D / revenue111.0%324.0%49.7%182.5%246.5%254.0%1307.7%209.9%168.7%179.4%
CapEx / revenue3.1%2.1%0.6%0.0%1.9%3.6%134.6%6.3%0.4%2.4%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ONMDW in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-15View SEC filing
10-K · Filed 2026-03-30View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-14View SEC filing

Companies in the same industry

Reconciliation checks needing review

6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2025-06-30

Difference 2600000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2023-09-30

Difference 36173554 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2023-06-30

Difference 58907531 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2023-03-31

Difference 51756689 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2022-12-31

Difference 17644000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.

balance equationreview2022-09-30

Difference 120133869 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.